2026年5月26日 · 自动抓取 · 最新研究 · 1 分钟阅读

Response to: Potential impact of NK-cell education on interferon efficacy in the ENDURE trial

Leukemia, Published online: 26 May 2026; doi:10.1038/s41375-026-02985-4Response to: Potential impact of NK-cell education on interferon efficacy in the ENDURE trial

本文自动抓取自 Leukemia，原文链接：Response to: Potential impact of NK-cell education on interferon efficacy in the ENDURE trial

原文发布日期：2026-05-26

Back to Blog

View All Posts »

Germline cancer risk alleles drive myelodysplastic neoplasms throughout adulthood

Leukemia, Published online: 13 July 2026; doi:10.1038/s41375-026-03052-8Germline cancer risk alleles drive myelodysplastic neoplasms throughout adulthood

Reversible and irreversible BTK inhibition promotes stem-like functional multipotency, persistence, and antitumor efficacy of CD19-directed CAR T cells in mantle cell lymphoma

Leukemia, Published online: 09 July 2026; doi:10.1038/s41375-026-03032-yReversible and irreversible BTK inhibition promotes stem-like functional multipotency, persistence, and antitumor efficacy of CD

Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology

Leukemia, Published online: 07 July 2026; doi:10.1038/s41375-026-03036-8Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology

Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies

Leukemia, Published online: 07 July 2026; doi:10.1038/s41375-026-03012-2Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chro

Related Posts

Germline cancer risk alleles drive myelodysplastic neoplasms throughout adulthood

Reversible and irreversible BTK inhibition promotes stem-like functional multipotency, persistence, and antitumor efficacy of CD19-directed CAR T cells in mantle cell lymphoma

Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology

Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies